What are the indications, dosing regimen, contraindications, and common adverse effects of Adderall ER (extended‑release mixed amphetamine salts) 20 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adderall ER 20 mg: Clinical Overview

Adderall ER (extended-release mixed amphetamine salts) 20 mg is a first-line stimulant medication for ADHD that works by inhibiting dopamine and norepinephrine reuptake, providing 12-hour symptom control with once-daily morning dosing.

Indications

Adderall ER is FDA-approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children (≥6 years), adolescents, and adults 1. Stimulants are recommended as first-line pharmacological therapy for ADHD, with the largest effect sizes for reducing core ADHD symptoms 2.

When to Initiate Treatment

  • Severe ADHD cases should be offered pharmacological treatment 2
  • Moderate severity cases can be offered treatment based on level of suffering, family situation, comorbidities, and psychosocial functioning 2
  • Always combine with behavioral interventions and psychoeducation 2
  • In preschool children (<6 years), use behavioral interventions first; pharmacotherapy only for very high severity 2

Dosing Regimen

Starting Dose

  • Begin with 10 mg once daily in the morning (not 20 mg initially) 3
  • The 20 mg dose represents a titrated dose, not a starting dose

Titration Schedule

Week-by-week escalation:

  • Week 1: 10 mg daily
  • Week 2: 20 mg daily (if needed)
  • Week 3: 30 mg daily (if needed)
  • Week 4: 40 mg daily (if needed)

3, 4

Dosing Considerations

  • Single morning dose provides 12-hour coverage 5, 6
  • Onset of action within 1.5 hours 5
  • Maximum recommended daily dose: 40 mg for amphetamines 3
  • For children <25 kg: use lower maximum doses (up to 35 mg total daily) 3
  • Titrate based on symptom response and tolerability, not body weight alone 3

Monitoring During Titration

At each visit, assess:

  • Height and weight (growth suppression risk) 2
  • Blood pressure and pulse (cardiovascular effects) 2
  • ADHD rating scales from parents and teachers 3
  • Adverse effects 3

Contraindications

Absolute Contraindications

  • Concomitant use with MAO inhibitors (risk of hypertensive crisis and cerebrovascular accident) 3
  • Active psychosis or schizophrenia (stimulants are psychotomimetic) 3
  • Glaucoma (may increase intraocular pressure) 3

Relative Contraindications (Use with Caution)

  • Serious cardiac disease - screen for structural cardiac abnormalities before initiating 1
  • Unstable mood disorder (can produce dysphoria) 3
  • History of stimulant abuse (requires closer monitoring, not absolute contraindication) 3

NOT Contraindications (Despite Package Insert Warnings)

  • Motor tics or Tourette's syndrome (controlled studies show methylphenidate does not worsen tics) 3
  • Controlled anxiety disorder (improves with treatment) 3
  • Controlled seizure disorder (stabilize on anticonvulsants first, then may use stimulants) 3

Common Adverse Effects

Most Frequent (from clinical trials)

In order of frequency:

  1. Decreased appetite/anorexia (25-36%) 7, 4
  2. Insomnia (12-20%) 7, 4
  3. Headache (16-19%) 7, 4
  4. Abdominal pain (11%) 7, 4
  5. Weight loss (9%) 4

2

Cardiovascular Effects

  • Increased blood pressure and pulse (monitor at each visit) 2
  • Most changes are statistically but not clinically significant 6, 4

Growth Effects

  • Monitor height and weight at every visit 2
  • Long-term growth suppression possible in pediatric patients 1

Psychiatric Effects

  • Rebound symptoms when medication wears off (afternoon/evening) 2
  • Rare: mood changes, irritability 2

Key Clinical Pearls

Advantages of Extended-Release Formulation

  • Once-daily dosing improves adherence 5
  • Eliminates need for school-based dosing 5
  • Consistent 12-hour coverage (demonstrated at 4- and 12-hour post-dose assessments) 6
  • Rapid onset within 1.5 hours 5

Common Pitfalls to Avoid

  1. Starting at 20 mg - always begin at 10 mg and titrate 3
  2. Inadequate monitoring - must assess height, weight, BP, and pulse regularly 2
  3. Stopping at first stimulant failure - if no response to amphetamines, try methylphenidate (90% respond to one or the other) 3
  4. Ignoring comorbidities - stimulants also improve oppositional defiant disorder and conduct disorder 2

Treatment Response

  • Expect rapid improvement within first week 6, 4
  • Effect size of 0.8 in adults 6
  • Dose-response relationship exists, particularly in severe cases 6
  • If inadequate response after proper titration, switch to methylphenidate before trying non-stimulants 2

Substance Control

  • Schedule II controlled substance - requires careful prescribing and monitoring 2
  • History of substance use disorder is not an absolute contraindication but requires enhanced monitoring 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.